Statistics

Total Visits

Views
Long-Term (52-Week) Results Of a Phase 3, Randomized, Controlled Trial Of Apremilast, An Oral Phosphodiesterase 4 Inhibitor, In Patients With Psoriatic Arthritis and Current Skin Involvement (PALACE 3)57

Select a period of time:

Number of views in the range

Views
Long-Term (52-Week) Results Of a Phase 3, Randomized, Controlled Trial Of Apremilast, An Oral Phosphodiesterase 4 Inhibitor, In Patients With Psoriatic Arthritis and Current Skin Involvement (PALACE 3)30

Views

Views
June 20251
July 20259
August 20252
September 20256
October 20256
November 20256
December 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil11
United States6
United Kingdom4
Ecuador2
Chile2
Argentina1
Switzerland1
Italy1
Kenya1
Mexico1
 

Top cities views

Views
Santiago2
Arraial do Cabo1
Buenos Aires1
Cajamar1
Contagem1
Cuenca1
Durham1
Jackson1
Medianeira1
Mexico City1